Get started
DIREXION SHARES ETF TRUSTDIREXION SHARES ETF TRUSTDIREXION SHARES ETF TRUST

DIREXION SHARES ETF TRUST

No trades
See on Supercharts
Overview Analysis News
Ideas
Discussions Seasonals

LABU trade ideas

LABU, my all in bet with a stop, of course.I honestly cannot find a better opportunity in the market than LABU currently. The ETF is XBI*3, which has demonstrated some major cyclicality and is currently selling below it's 2015 highs. My analysis is as follows: Record volumes on LABU specifically, but more or less XBI too. This implies we've hit a level of importance. It's quite clearly been consolidating for the past week; a sign that if we've bottomed out and that the strongest selling is in the past. It's normal for LABU to experience pull backs lasting, about 1 month, 3 months or whatever. We are currently 360 days into a -50% pullback on XBI and 30 days into another significant pullback now. The most recent leg down was clearly in relation to the entire market selloff, XBI was one of the sectors that was hardest hit during the price action. My view is as follows, I used the same logic during covid when I split my account between OVV and CCR: If conditions return to that of December, which were markedly poor, LABU will probably sell for 40, if conditions returned to October, 60 is entirely possible. Both possibilities are quite clearly in the cards for this year, and it looks like the market has already begun to turn around. My personal bias is that this sector is probably undervalued, because the firms that represent it are almost certainly worth more than what they sold for in 2015 (although I havent done any work on any of them) and my sub-grade technical analysis suggest that we've possibly hit a bottom, and you can find a great risk to reward trade by owning this security. At this time, with the price at 17.5~ I am 100% in LABU but I have the stop at 16.5. So my expected risk to reward is 10-1, which is unheard of. TL:DR XBI has fallen a lot. Its been down for a while. Volumes have hit a record in it's parent ETF, XBI If conditions return to December, I'll make 100%. If I'm wrong, I'll lose 7~%. Naturally, I have a strong conviction in the possibilities with this type of trade. I would strongly advise that you don't follow it. Despite the underlying being an ETF, it's clearly a high-risk high-reward type of deal.
AMEX:LABULong
by JamesMBee
22
LABU Bullish. LABUAs expected SNP Biotech sector is in the green and this has been reflected in our last update with every new and emerging biotech stock that we reviewed being convincingly bullish. We have and end to a zig zag formation here, this a corrective X Wave or a start of a new impulse ensures. We shall see which shall transpire in this instance. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
AMEX:LABULong
by Rykin_Capital
LABU and Deja Vu. $60 is key level for value investorsHello traders and investors One of the important ETFs from February 2020 is LABU. Too much upside potential with very low margin power to trade. VWAP is most important confirmation for value investing. LABU's chart is very look like "Deja Vu cycle" or "cup and handle pattern". 60.00 USD level is very important. NOW WHAT? It's very interesting if investors come back again in LABU because the Risk/Reward Ratio is more than 7 and it's up to 13. Position type: Buy Limit ENTRY: 59.25 TP1: 127.98 TP2: 182.81 SL: 49.70 symbol="AMEX:LABU"]AMEX:LABU
AMEX:LABULong
by StockAndMoreCom
3